Lauren White
Chief Financial Officer, C4 Therapeutics (United States).
Companies
- Seaport Therapeutics, Inc.Chief financial officer Apr 30, 2026 to now1
- ImmunoGen Inc.Chief financial officer Sep 19, 2023 to Feb 12, 20242
- C4 Therapeutics (United States)Chief financial officer Jun 21, 2021 to Aug 31, 20233
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Seaport Therapeutics, Inc. SPTX6,702 shares4$117.7K at $17.57May 4, 2026
C4 Therapeutics (United States) CCCC32,686 shares5$94.3K at $2.88Aug 30, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- May 4, 2026Converted 6,702 shares of Seaport Therapeutics, Inc.4
- Aug 30, 2023Shares withheld for tax 661 shares at $2.93 of C4 Therapeutics (United States)5
- Aug 30, 2023Exercised options 2,250 shares of C4 Therapeutics (United States)5
- Feb 13, 2023Granted 26,000 shares of C4 Therapeutics (United States)6
- Jan 30, 2023Shares withheld for tax 1,301 shares at $7.78 of C4 Therapeutics (United States)7
- Jan 30, 2023Exercised options 3,750 shares of C4 Therapeutics (United States)7
- May 26, 2022Shares withheld for tax 1,102 shares at $7.01 of C4 Therapeutics (United States)8
- May 25, 2022Exercised options 3,750 shares of C4 Therapeutics (United States)9
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6SEC EDGARForm 4 filed Feb 15, 2023
- 7SEC EDGARForm 4 filed Feb 1, 2023
- 8SEC EDGARForm 4 filed Jun 14, 2022
- 9SEC EDGARForm 4 filed May 27, 2022